Lauren K. Wasson

Lauren K. Wasson

Auto-generated profile, based on publicly available information

Lauren K. Wasson

Harvard Medical School

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2020 in Nature Genetics
Verified
Journal Article
Open access
PDF file
FRFelix Richter
Felix Richter
SMSarah U. Morton
Sarah U. Morton
SKSeong Won Kim
Seong Won Kim
AKAlexander Kitaygorodsky
Alexander Kitaygorodsky
LWLauren K. Wasson
Lauren K. Wasson
BGBruce D. Gelb
Bruce D. Gelb
A genetic etiology is identified for one-third of patients with congenital heart disease (CHD), with 8% of cases attributable to coding de novo variants (DNVs). To assess the contribution of noncoding DNVs to CHD, we compared genome sequences from 749 CHD probands and their parents with those from 1,611 unaffected trios. Neural network prediction of noncoding DNV transcriptional impact identified a burden of DNVs in individuals with CHD (n = 2,238 DNVs) compared to controls (n = 4,177; P = 8.7 × 10−4). Independent analyses of enhancers showed an excess of DNVs in associated genes (27 genes versus 3.7 expected, P = 1 × 10−5). We observed significant overlap between these transcription-based approaches (odds ratio (OR) = 2.5, 95% confidence interval (CI) 1.1–5.0, P = 5.4 × 10−3). CHD DNVs altered transcription levels in 5 of 31 enhancers assayed. Finally, we observed a DNV burden in RNA-binding-protein regulatory sites (OR = 1.13, 95% CI 1.1–1.2, P = 8.8 × 10−5). Our findings demonstrate an enrichment of potentially disruptive regulatory noncoding DNVs in a fraction of CHD at least as high as that observed for damaging coding DNVs.

28 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
BABrynn N. Akerberg
Brynn N. Akerberg
FGFei Gu
Fei Gu
NVNathan VanDusen
Nathan VanDusen
XZXiaoran Zhang
Xiaoran Zhang
RDRui Dong
Rui Dong
WPWilliam Pu
William Pu
Mapping the chromatin occupancy of transcription factors (TFs) is a key step in deciphering developmental transcriptional programs. Here we use biotinylated knockin alleles of seven key cardiac TFs (GATA4, NKX2-5, MEF2A, MEF2C, SRF, TBX5, TEAD1) to sensitively and reproducibly map their genome-wide occupancy in the fetal and adult mouse heart. These maps show that TF occupancy is dynamic between developmental stages and that multiple TFs often collaboratively occupy the same chromatin region through indirect cooperativity. Multi-TF regions exhibit features of functional regulatory elements, including evolutionary conservation, chromatin accessibility, and activity in transcriptional enhancer assays. H3K27ac, a feature of many enhancers, incompletely overlaps multi-TF regions, and multi-TF regions lacking H3K27ac retain conservation and enhancer activity. TEAD1 is a core component of the cardiac transcriptional network, co-occupying cardiac regulatory regions and controlling cardiomyocyte-specific gene functions. Our study provides a resource for deciphering the cardiac transcriptional regulatory network and gaining insights into the molecular mechanisms governing heart development.

1 February 2016 in Developmental Cell
Verified
Journal Article
Closed access
LWLauren Waldron
Lauren Waldron
JSJeffrey D. Steimle
Jeffrey D. Steimle
TGTodd M. Greco
Todd M. Greco
NGNicholas C. Gomez
Nicholas C. Gomez
KDKerry M. Dorr
Kerry M. Dorr
Frank ConlonFrank Conlon
Frank Conlon

11 June 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CWCaralynn M. Wilczewski
Caralynn M. Wilczewski
AHAustin J. Hepperla
Austin J. Hepperla
TSTakashi Shimbo
Takashi Shimbo
LWLauren Wasson
Lauren Wasson
ZRZachary L. Robbe
Zachary L. Robbe
Frank ConlonFrank Conlon
Frank Conlon
Significance: Birth defects are the leading cause of infant mortality in the United States and Europe, with cardiac defects being the most prevalent. Here we define the requirement and mechanism of action of CHD4, the catalytic core component of the nucleosome remodeling and deacetylase (NuRD) complex, in embryonic heart development. CHD4 is essential from fly to human and mutations in CHD4 are causative to congenital heart disease, including atrial and ventricular septal defects. By generating a cardiac conditional null allele of CHD4, temporal transcriptional profiling, and systems-level analysis of CHD4 target genes and in utero echocardiography, we define molecular, biochemical, anatomical, and physiological mechanisms for CHD4 and the NuRD complex in repressing inappropriate expression of the skeletal and smooth muscle programs in the developing heart.

24 January 2018 in Current Protocols in Human Genetics
Verified
Journal Article
Open access
PDF file
ASArun Sharma
Arun Sharma
CTChristopher N. Toepfer
Christopher N. Toepfer
TWTarsha Ward
Tarsha Ward
LWLauren Wasson
Lauren Wasson
RARadhika Agarwal
Radhika Agarwal
CSChristine Seidman
Christine Seidman
Human induced pluripotent stem cells (hiPSCs) can be used to mass produce surrogates of human tissues, enabling new advances in drug screening, disease modeling, and cell therapy. Recent developments in clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing technology use homology‐directed repair (HDR) to efficiently generate custom hiPSC lines harboring a variety of genomic insertions and deletions. Thus, hiPSCs that encode an endogenous protein fused to a fluorescent reporter protein can be rapidly created by employing CRISPR/Cas9 genome editing, enhancing HDR efficiency and optimizing homology arm length. These fluorescently tagged hiPSCs can be used to visualize protein function and dynamics in real time as cells proliferate and differentiate. Given that nearly any intracellular protein can be fluorescently tagged, this system serves as a powerful tool to facilitate new discoveries across many biological disciplines. In this unit, we present protocols for the design, generation, and monoclonal expansion of genetically customized hiPSCs encoding fluorescently tagged endogenous proteins. © 2018 by John Wiley & Sons, Inc.

15 October 2020 in eLife
Verified
Journal Article
Open access
ASArun Sharma
Arun Sharma
LWLauren K Wasson
Lauren K Wasson
JWJon AL Willcox
Jon AL Willcox
SMSarah U Morton
Sarah U Morton
JGJoshua M Gorham
Joshua M Gorham
PCPediatric Cardiac Genomics Consortium
Pediatric Cardiac Genomics Consortium
Damaging GATA6 variants cause cardiac outflow tract defects, sometimes with pancreatic and diaphragmic malformations. To define molecular mechanisms for these diverse developmental defects, we studied transcriptional and epigenetic responses to GATA6 loss of function (LoF) and missense variants during cardiomyocyte differentiation of isogenic human induced pluripotent stem cells. We show that GATA6 is a pioneer factor in cardiac development, regulating SMYD1 that activates HAND2, and KDR that with HAND2 orchestrates outflow tract formation. LoF variants perturbed cardiac genes and also endoderm lineage genes that direct PDX1 expression and pancreatic development. Remarkably, an exon 4 GATA6 missense variant, highly associated with extra-cardiac malformations, caused ectopic pioneer activities, profoundly diminishing GATA4, FOXA1/2, and PDX1 expression and increasing normal retinoic acid signaling that promotes diaphragm development. These aberrant epigenetic and transcriptional signatures illuminate the molecular mechanisms for cardiovascular malformations, pancreas and diaphragm dysgenesis that arise in patients with distinct GATA6 variants.